MetLife, Inc.

New York Stock Exchange
Back to all articles
Bullish +75

MetLife Q1 Earnings Call Highlights

AI-generated analysis

📈 MetLife reported strong Q1 2026 results with adjusted earnings of $1.6 billion ($2.42/share), an 18% increase from the prior year.

💰 Net income was $1.1 billion ($1.74/share), primarily affected by net investment losses from normal trading and a partial private equity sale.

📊 Adjusted revenue excluding pension risk transfers rose 10%, while return on equity reached 17% at the top end of its target range.

💼 Group Benefits adjusted earnings surged 19% to $439 million, driven by exceptional life mortality and favorable working population trends.

💊 Analysts noted potential mortality drivers like GLP-1 drugs could lead to gradual pricing adjustments if favorability persists long-term.

🏦 Retirement and Income Solutions (RIS) adjusted earnings grew 11% to $451 million, boosted by higher variable investment income and favorable underwriting.

🌏 International businesses showed broad growth, with Asia earning $487 million (up 31%) led by strong sales in Japan and Korea.

📉 Latin America earnings were $229 million but down 9% on a constant currency basis due to tax changes in Mexico.

🚀 EMEA adjusted earnings jumped 33% to $110 million as multi-year sales growth translated into premium increases.

🏢 MetLife Investment Management (including PineBridge) earned $47 million in its first fully integrated quarter, exceeding February outlooks.

💸 Institutional outflows of about $2 billion were observed due to market volatility and platform integration, though the pipeline remains strong.

🇯🇵 Japan sales rose 26% on a constant currency basis, highlighted by a new corporate accident and health product launch.

💰 Korea sales increased 44%, supported by strength in both U.S. dollar and Korean won products amid rising equity markets.

🌍 MetLife stated that current geopolitical situations in the Middle East have not materially impacted EMEA or the company overall.

⚙️ Management emphasized disciplined capital management under its New Frontier strategy as a key driver of top-line growth across all segments.

Bullish Signals
  • MetLife reported adjusted earnings of $1.6 billion for Q1, representing an 18% year-over-year increase driven by broad-based growth across all operating businesses.
  • Adjusted earnings per share surged 23% to $2.42, reflecting the full earnings power of the company and disciplined capital management under the New Frontier strategy.
  • Group Benefits adjusted earnings grew 19% to $439 million, aided by exceptional life mortality ratios of 80.1%, which outperformed the annual target range of 83% to 88%.
  • Group Benefits sales increased 15% driven by double-digit growth in voluntary products and improved persistency, particularly in dental lines.
  • Retirement and Income Solutions (RIS) delivered adjusted earnings up 11% to $451 million, supported by a total investment spread of 119 basis points at the top end of guidance.
  • International businesses demonstrated robust expansion with Asia adjusted earnings rising 31% and Latin America sales growing 20% on a constant currency basis.
  • Asia region sales grew 22% led by strong performance in Japan, where accident and health sales surged 77%, and Korea, which saw a 44% increase in sales.
  • MetLife Investment Management achieved its first fully integrated quarter after the PineBridge acquisition with adjusted earnings up to $47 million.
  • Outflows in the investment management business stabilized later in the quarter, and forward commitments remained strong particularly within private assets.
Risk Factors
  • MetLife incurred net investment losses primarily due to normal trading activity within its fixed maturity portfolio, along with a modest loss tied to the sale of private equity limited partnership interests.
  • The direct expense ratio improved to 11.9%, which is still above the company's 2026 annual target of 12.1%.
  • Core spread excluding variable investment income decreased by 4 basis points sequentially as MetLife rotated assets tied to large fourth-quarter pension risk transfer inflows.
  • Latin America adjusted earnings declined 9% on a constant currency basis, caused by Mexico's value-added tax change and less favorable taxes.
  • Institutional client outflows amounted to approximately $2 billion during the quarter, driven by market volatility, normal allocation shifts, and integration effects between MetLife and PineBridge.
  • Potential drivers of favorable mortality trends, such as GLP-1 drugs, may be temporary pull-forward effects rather than sustainable structural changes.
Full Analysis
MetLife (NYSE:MET) reported a robust start to its financial year in 2026, with the company highlighting broad-based growth across operating businesses and favorable underwriting trends under its New Frontier strategy. Adjusted earnings for the quarter came in at $1.6 billion, or $2.42 per share, representing an 18% increase from the prior year period, while adjusted earnings per share climbed 23%. The stronger adjusted results were partly attributed to disciplined capital management, although net investment losses from normal trading activity and a modest loss on private equity sales caused reported net income to be lower at $1.1 billion or $1.74 per share. Revenue grew 10% year-over-year excluding pension risk transfers, and return on equity hit the top end of its target range at 17%. Within specific business segments, Group Benefits saw adjusted earnings rise 19% to $439 million, driven by exceptional life mortality which came in at 80.1%, surpassing its target range of 83% to 88%. Executives noted that this favorability could be influenced by factors such as GLP-1 drugs and potential post-pandemic effects, with MetLife planning to gradually adjust pricing if these trends continue. Retirement and Income Solutions reported an 11% increase in adjusted earnings to $451 million, supported by higher variable investment income and favorable margins, while the company maintains a full-year guidance of $1.6 billion to $1.8 billion for this segment. International operations also delivered significant growth, with Asia's adjusted earnings surging 31% to $487 million. This expansion was led by strong performance in Japan and Korea; Japan sales increased 26% on a constant currency basis due to a mix of product launches and strength in both yen and dollar products, while Korean sales grew 44% driven by U.S. dollar products. Latin America saw earnings rise 5% year-over-year despite a tax-related headwind in Mexico, and EMEA adjusted earnings jumped 33%, with the company stating that recent geopolitical tensions in the Middle East have not yet had a material impact on its overall operations. On the investment side, MetLife Investment Management reported an 89% increase in adjusted earnings to $47 million following the first fully integrated quarter after acquiring PineBridge. While institutional client outflows of approximately $2 billion occurred during the quarter due to market volatility and allocation shifts, management indicated that these flows had stabilized later in the quarter and that the pipeline for private assets remained strong. The company is continuing its integration of the two platforms to leverage business growth and favorable expense margins from the combined entity.